PL2668205T3 - Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie - Google Patents

Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie

Info

Publication number
PL2668205T3
PL2668205T3 PL12701866T PL12701866T PL2668205T3 PL 2668205 T3 PL2668205 T3 PL 2668205T3 PL 12701866 T PL12701866 T PL 12701866T PL 12701866 T PL12701866 T PL 12701866T PL 2668205 T3 PL2668205 T3 PL 2668205T3
Authority
PL
Poland
Prior art keywords
derived peptides
human lactoferrin
lactoferrin derived
human
peptides
Prior art date
Application number
PL12701866T
Other languages
English (en)
Inventor
Margit Mahlapuu
Camilla Björn
Veronika Sjöstrand
Björn Walse
Bo Svensson
Original Assignee
Pergamum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pergamum Ab filed Critical Pergamum Ab
Publication of PL2668205T3 publication Critical patent/PL2668205T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL12701866T 2011-01-26 2012-01-25 Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie PL2668205T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11152213A EP2481751A1 (en) 2011-01-26 2011-01-26 Human lactoferrin derived peptides

Publications (1)

Publication Number Publication Date
PL2668205T3 true PL2668205T3 (pl) 2017-09-29

Family

ID=44123487

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12701866T PL2668205T3 (pl) 2011-01-26 2012-01-25 Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie

Country Status (13)

Country Link
US (2) US9132165B2 (pl)
EP (3) EP2481751A1 (pl)
JP (2) JP6158713B2 (pl)
KR (2) KR101933900B1 (pl)
CN (2) CN103459419B (pl)
AU (2) AU2012210565B2 (pl)
BR (2) BR112013018365A2 (pl)
CA (2) CA2825246A1 (pl)
ES (2) ES2633353T3 (pl)
MX (2) MX341020B (pl)
PL (1) PL2668205T3 (pl)
RU (2) RU2596393C2 (pl)
WO (2) WO2012101156A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
CN104888202A (zh) * 2014-05-22 2015-09-09 闫牧乔 一种治疗扁桃体炎的药物
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
RU2681216C1 (ru) * 2018-09-05 2019-03-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala
RU2681310C1 (ru) * 2018-09-05 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala
KR102032945B1 (ko) * 2018-12-03 2019-10-16 순천대학교 산학협력단 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물
NL2024839B1 (en) * 2020-02-05 2021-09-13 Cbmr Scient Nanoscience B V Antimicrobial peptide for treatment and controlling skin disorders relating to microbial infection

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
JP2001504447A (ja) 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
SE9804614A0 (en) 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
IL146130A0 (en) * 1999-05-14 2002-07-25 Univ California Anti-inflammatory therapy for inflammatory mideated infection
WO2001034641A2 (en) 1999-11-11 2001-05-17 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
RU2165769C1 (ru) * 2000-07-13 2001-04-27 Якубовская Раиса Ивановна Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения
SE0102067D0 (sv) 2001-06-11 2001-06-11 A & Science Invest Ab Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
WO2008006125A1 (en) * 2006-07-10 2008-01-17 Österreichische Akademie der Wissenschaften Antimicrobial peptides
JP5384948B2 (ja) * 2007-02-09 2014-01-08 ジェノミディア株式会社 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
JP5444544B2 (ja) * 2007-02-09 2014-03-19 ジェノミディア株式会社 血管新生誘導剤及びそれに用いられるポリペプチド
EP2050461A1 (en) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2060586A1 (en) * 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB New synthetic arginine substituted peptides and their use
CN101809029B (zh) * 2008-05-23 2016-06-15 第一三共株式会社 具有延长目标肽的血浆半衰期作用的肽
PL2387390T3 (pl) * 2009-01-13 2013-12-31 Pergamum Ab Zawierające kwas hialuronowy kompozycje do leczenia ran, blizn oraz zrostów powstających po zabiegach chirurgicznych
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
KR101341210B1 (ko) * 2013-01-24 2013-12-12 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 신규한 항균 펩타이드 및 이의 용도

Also Published As

Publication number Publication date
RU2013139294A (ru) 2015-03-10
KR20140020252A (ko) 2014-02-18
RU2013139302A (ru) 2015-03-10
US9132165B2 (en) 2015-09-15
BR112013018365A2 (pt) 2016-08-30
KR101949210B1 (ko) 2019-02-18
JP6158713B2 (ja) 2017-07-05
EP2668205A1 (en) 2013-12-04
MX2013007995A (es) 2013-12-02
AU2012210565B2 (en) 2017-03-30
RU2596393C2 (ru) 2016-09-10
ES2633353T3 (es) 2017-09-20
MX342313B (es) 2016-09-26
EP2668205B1 (en) 2017-05-10
MX2013008530A (es) 2013-12-09
EP2668204B1 (en) 2017-09-27
US20140031296A1 (en) 2014-01-30
WO2012101156A3 (en) 2013-05-30
BR112013018264A2 (pt) 2016-08-30
US8846608B2 (en) 2014-09-30
AU2012210564B2 (en) 2016-10-27
CN103459419B (zh) 2016-05-11
CN103459419A (zh) 2013-12-18
JP6158712B2 (ja) 2017-07-05
JP2014505061A (ja) 2014-02-27
CA2825247A1 (en) 2012-08-02
US20130310306A1 (en) 2013-11-21
WO2012101157A1 (en) 2012-08-02
ES2645959T3 (es) 2017-12-11
EP2481751A1 (en) 2012-08-01
KR20140026367A (ko) 2014-03-05
KR101933900B1 (ko) 2018-12-31
MX341020B (es) 2016-08-04
CN103476792A (zh) 2013-12-25
JP2014505062A (ja) 2014-02-27
EP2668204A2 (en) 2013-12-04
RU2593757C2 (ru) 2016-08-10
CA2825246A1 (en) 2012-08-02
WO2012101156A2 (en) 2012-08-02
CN103476792B (zh) 2015-11-25

Similar Documents

Publication Publication Date Title
IL230918A0 (en) Modified proteins and peptides
HK1200489A1 (en) Recombinant human naglu protein and uses thereof naglu
IL279676A (en) Recombinant proteins and therapeutic uses
IL232247A0 (en) Polypeptide structures and their uses
EP2870170A4 (en) NOVEL PEPTIDES AND THEIR USE
IL222027A (en) Peptides and their use
SG184289A1 (en) Novel peptides and methods for their preparation and use
ZA201307641B (en) Human tissue factor antibody and uses thereof
EP2782589A4 (en) ANTIMICROBIAL PEPTIDES AND METHOD FOR THEIR USE
EP2799540A4 (en) HUMAN ARGINASE AND PEGYLATED HUMAN ARGINASE AND USE THEREOF
EP2738255A4 (en) PEPTIDE FROM ERAP1 AND ITS USE
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
PL2668205T3 (pl) Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie
SG11201501646PA (en) Peptides and their uses
EP2793921A4 (en) PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF
EP2796462A4 (en) ANTITUMOR PEPTIDE AND USE THEREOF
EP2907870A4 (en) REPROGRAMMING PEPTIDE AND USE THEREOF
EP2762149A4 (en) PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF
EP2734543A4 (en) LACTOFERRIN FRAGMENTS AND USE THEREOF
EP2918600A4 (en) NEW PEPTIDE AND ITS USE
IL230474B (en) Lactoferrin segments and their uses
GB201121236D0 (en) Proteins and peptides
GB201121226D0 (en) Modified proteins and peptides
GB201121233D0 (en) Modified proteins and peptides
GB201117876D0 (en) Peptides and their use in treatment